World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 18 April 2017
Main ID:  ChiCTR-TRC-14004508
Date of registration: 2014-04-07
Prospective Registration: No
Primary sponsor: Xuanwu Hospital, Capital Medical University
Public title: Simultaneous combination of anesthetic and hypothermia to treat refractory status epilepticus
Scientific title: Simultaneous combination of anesthetic and hypothermia to treat refractory status epilepticus
Date of first enrolment: 2013-01-01
Target sample size: intervention group:20;intervention group:20;
Recruitment status: Recruiting
URL:  http://www.chictr.org.cn/showproj.aspx?proj=5064
Study type:  Interventional study
Study design:  Randomized parallel controlled trial  
Phase:  Other
Countries of recruitment
China
Contacts
Name: Su Yingying   
Address:  45 Changchun Street, Xicheng District, Beijing, China 100053
Telephone: +86 15699959572
Email: tangsuyingying@sina.com
Affiliation:  Xuanwu Hospital, Capital Medical University
Name: Su Yingying   
Address:  45 Changchun Street, Xicheng District, Beijing, China 100053
Telephone: +86 15699959572
Email: tangsuyingying@sina.com
Affiliation:  Xuanwu Hospital, Capital Medical University
Key inclusion & exclusion criteria
Inclusion criteria: All patients were 14 years or older (patients aged less than 14 years is admitted to pediatrics clinics in China); RSE is defined as either clinical or electrographic seizures after receiving adequate doses of an initial benzodiazepine followed by a second acceptable antiepileptic drug (AED).
Exclusion criteria: 1. Unstable vital signs, such as a pulse of <60 beats per minute, a systolic blood pressure of <90 mmHg, or an arterial blood oxygen saturation of <90%;
2. Severe systemic diseases: such as cardiac arrhythmias (second- or third-degree atrioventricular block, sustained ventricular tachyarrhythmia), chronic obstructive pulmonary disease, liver or kidney dysfunction( total bilirubin>34.2µmol/L, Cr>104µmol/L), Coagulation disorders(platelets<75*109/L, INR>1.3, APTT>1.53*upper limit of normal range, Fib<2g/L);
3. Pregnancy;
4. contraindication of anesthetics: such as schizophrenia, depressive state, myasthenia gravis, allergy to benzodiazepines and so on.


Age minimum: 14
Age maximum: 75
Gender: Both
Health Condition(s) or Problem(s) studied
refractory status epilepticus
Intervention(s)
intervention group:intravenous anesthetic;intervention group:hypothermia;
Primary Outcome(s)
clinical and(or) EEG termination of seizures;decrease of seizures;recurrence;mortality at 3 months;GOS score at 3 months;circulation inhibition;post-SE symptomatic epilepsy at 3 month;
Secondary Outcome(s)
liver dysfunction;kidney dysfunction;EEG patterns before hypothermia;EEG patterns after hypothermia;duration in NICU;duration of hospitalization;
Secondary ID(s)
Source(s) of Monetary Support
No
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history